Wed. 17 Apr 2024, 5:23am ET
Benzinga
News
4 Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, &ldquo, Company&rdquo, , &ldquo, GTG&rdquo, )), a global leader in genomicsbased tests in health, wellness and serious disease, is pleased to announce the Company has established a precision oncology division and announced its highly anticipated portfolio of new diagnostic tests under its geneType precision oncology brand.